Jul 18, 2022
Enterome, a clinical stage biopharmaceutical company developing first-in-class immunomodulatory drugs based on its highly productive bacterial Mimicry drug discovery platform, today announces that it has signed a strategic R&D collaboration and license agreement...
Feb 24, 2022
Inflammatory Bowel Disease (IBD) affects approximately 40,000 patients in Ireland, with 25% of these cases as childhood inflammatory bowel disease. Globally, the prevalence for IBD is 396 cases per 100,000 persons annually. Symptoms include abdominal pain, persistent...
Jan 14, 2022
The partnership will involve up to 1,000 patients and leverage the foundation’s repository of biospecimens and data to advance the development of Coral’s Functional Response Score – a precision medicine clinical test for patients with autoimmune diseases including...
Oct 5, 2021
Celltrion Healthcare recently announced two data sets relating to the use of the subcutaneous formulation of infliximab, Remsima® SC (CT-P13 SC), in inflammatory bowel disease (IBD) at a poster presentation at United European Gastroenterology (UEG) Week 2021,...
Sep 6, 2021
A team of researchers led by a biomedical scientist at the University of California, Riverside, has identified a novel mechanism by which loss-of-function mutations in the gene PTPN2, found in many patients with inflammatory bowel disease, or IBD, affect how...
